drugset
drugset / Trial / NCT01416948

Cognitive REmediation After Trauma Exposure Trial = CREATE Trial

NCT01416948 ↗

Phase 2 Terminated 32 enrolled INTRuST, Post-Traumatic Stress Disorder - Traumatic Brain Injury Clinical Consortium U.S. Army Medical Research and Development Command · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will evaluate the efficacy of methylphenidate and galantamine in the treatment of persistent cognitive symptoms associated with posttraumatic stress disorder (PTSD) and/or traumatic brain injury (TBI).

Timeline

Start
2011-08
Primary completion
2013-03
Completion
2013-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Galantamine Small molecule 12 mg —
Subject Methylphenidate Small molecule 20 mg —

Indications

post-traumatic stress disorder traumatic brain injury